Katherine Roe, CEO at Wentworth Resources talks through the Ruvuma gas development in Tanzania. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.48
Bid: 31.34
Ask: 32.48
Change: 0.48 (1.50%)
Spread: 1.14 (3.64%)
Open: 32.02
High: 32.48
Low: 31.20
Prev. Close: 32.00
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
23rd Jun 20224:40 pmRNSSecond Price Monitoring Extn
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
15th Jun 20222:30 pmRNSHolding(s) in Company
9th Jun 20223:00 pmRNSExercise of Options and Total Voting Rights
6th Jun 20224:25 pmRNSPosting of Annual Report & Notice of AGM
25th May 20227:00 amRNSFull Year Results
18th May 20224:36 pmRNSPrice Monitoring Extension
16th May 20227:00 amRNSSynairgen presents at ATS 2022
25th Apr 20227:00 amRNSPresentation at ECCMID
19th Apr 20224:40 pmRNSSecond Price Monitoring Extn
19th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20222:10 pmRNSHolding(s) in Company
5th Apr 20227:00 amRNSSynairgen to present at ATS 2022
17th Mar 20227:25 amRNSSynairgen Provides Update on ACTIV-2 Trial
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
11th Mar 20224:40 pmRNSSecond Price Monitoring Extn
11th Mar 20224:35 pmRNSPrice Monitoring Extension
8th Mar 20224:35 pmRNSHolding(s) in Company
8th Mar 20223:52 pmRNSHolding(s) in Company
4th Mar 20221:36 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSUpdate on SNG001
24th Feb 202211:30 amRNSHolding(s) in Company
23rd Feb 202211:25 amRNSHolding(s) in Company
21st Feb 20227:00 amRNSTopline results from Phase 3 SPRINTER trial
4th Feb 20224:54 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20222:05 pmRNSHolding(s) in Company
12th Jan 202211:53 amRNSHolding(s) in Company
7th Jan 20225:25 pmRNSHolding(s) in Company
6th Jan 202212:00 pmRNSSynairgen announces partnership with Ashfield
23rd Dec 20214:15 pmRNSHolding(s) in Company
23rd Dec 20212:19 pmRNSHolding(s) in Company
21st Dec 20215:05 pmRNSHolding(s) in Company
8th Dec 20217:00 amRNSData Presented at ESWI Influenza Conference
6th Dec 20215:30 pmRNSHolding(s) in Company
6th Dec 20217:00 amRNSSynairgen Presents SNG001 Data at ESWI
19th Nov 20212:26 pmRNSHolding(s) in Company
11th Nov 20217:00 amRNSSynairgen completes Phase III recruitment
8th Nov 202112:58 pmRNSHolding(s) in Company
26th Oct 20213:13 pmRNSHolding(s) in Company
21st Oct 20215:39 pmRNSHoldings in Company
21st Oct 20217:00 amRNSGrant of Options
20th Oct 20217:00 amRNSSNG001 progresses to Phase 3 of ACTIV-2 trial
13th Oct 20217:00 amRNSSynairgen appoints Gareth Walters, Ph.D. as CRO
5th Oct 202111:25 amRNSHolding(s) in Company
30th Sep 20217:02 amRNSNon-Executive Director Appointment
30th Sep 20217:00 amRNSInterim results
21st Sep 20217:00 amRNSSynairgen Notice of Interim Results
10th Sep 202111:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.